Erythropoietin (Epo), the main erythropoiesis‐stimulating factor widely prescribed to
overcome anemia, is also known nowadays for its cytoprotective action on non …

Breakthroughs with rapid changes are the themes of the development in Neurorestoratology
this year. Given the very difficult circumstances of the persistent COVID-19 pandemic, most …

Aim To evaluate safety and motor function after treatment with allogeneic umbilical cord
blood (AlloCB) or umbilical cord tissue‐derived mesenchymal stromal cells (hCT‐MSC) in …

Importance Perinatal arterial ischemic stroke (PAIS) is a focal brain injury in term neonates
that is identified postnatally but is presumed to occur near the time of birth. Many pregnancy …

Background aims Umbilical cord blood (UCB) infusion is being investigated as a treatment
for a range of neurological conditions, primarily because of its potent immunomodulatory …

Neurorestorative treatments have been able to improve the quality of life for patients
suffering from neurological diseases and damages since the concept of Neurorestoratology …

Neurorestoratology constitutes a novel discipline aimed at the restoration of damaged
neural structures and impaired neurological functions. This area of knowledge integrates …

Introduction The current multi-center, randomized, double-blind study was conducted among
children with cerebral palsy (CP) to assess the safety and efficacy of umbilical cord blood …

Cell therapies are an emergent treatment for cerebral palsy (CP) with promising evidence
demonstrating efficacy for improving gross motor function. However, families value …

Neonatal hypoxic-ischemic encephalopathy (HIE) is a common disease among newborns,
which is a leading cause of neonatal death and permanent neurological sequelae …